DHVI GMP production of N332-GT1 20 mut vaccine candidate to target N332 supersite bnAbs developed for the Scripps CHAVI-ID team
Research Grant
Administered By
Medicine, Duke Human Vaccine Institute
Awarded By
Scripps Research Institute
Start Date
February 1, 2018
End Date
June 30, 2018
Administered By
Medicine, Duke Human Vaccine Institute
Awarded By
Scripps Research Institute
Start Date
February 1, 2018
End Date
June 30, 2018